Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. exercised options for 31,797 Fennec Pharmaceuticals Inc. shares (Form 4)

Traded Mar 28 to Mar 31, 2026 · Filed Apr 2, 2026

From Mar 28 to Mar 31, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) exercised options for 31,797 Fennec Pharmaceuticals Inc. shares, leaving 46,564 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
31,797 shares
Holding after
46,564 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 28, 2026Common SharesOption exercise13,94360,507Direct
Mar 31, 2026Common SharesOption exercise16,69545,405Direct
Mar 31, 2026Common SharesOption exercise1,15946,564Direct

Source

View original at SEC

Related